Visualization of the cervical spinal cord with FDG and high-resolution PET

Journal of Computer Assisted Tomography

Volumn 22, Issue 3, 1998, Pages 487-491

  Kamoto, Yoko ^a   Sadato, Norihiro ^b   Yonekura, Yoshiharu ^b   Tsuchida, Tatsuro ^b   Uematsu, Hidemasa ^b   Waki, Atsuo ^b   Uchida, Kenzo ^b   Baba, Hisatoshi ^b   Imura, Shinichi ^b   Konishi, Junji ^a  

^a KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Emission computed tomography (PET); Fluorodeoxyglucose (FDG); Spinal cord; Spinal cord, abnormalities; Spinal cord, anatomy

Indexed keywords

COMPUTERIZED TOMOGRAPHY; MEDICAL IMAGING; POSITRON EMISSION TOMOGRAPHY; VISIBILITY;

CERVICAL SPINAL CORD; EMISSION COMPUTED TOMOGRAPHY; EMISSION COMPUTED TOMOGRAPHY (PET); FLUORODEOXYGLUCOSE; SPINAL CORD, ABNORMALITY; SPINAL CORD, ANATOMY; SPINAL-CORD;

GLUCOSE;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CERVICAL SPINAL CORD; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; SPINAL CORD DISEASE;

EID: 0031829901     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199805000-00023     Document Type: Article

References (17)

1. Borbely K, Fulham MJ, Brooks RA, Di Chiro G. PET-fluorodeoxyglucose of cranial and spinal neuromas. J Nucl Med 1992;33:1931-4.
2. Alavi A, Kramer E, Wegener W, Alavi J. Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor. J Nucl Med 1990;31:360-4.
3. 11C-methionine. J Comput Assist Tomogr 1990;14:297-9.
4. 18F-2-deoxyglucose in normal and pathological cases. J Comput Assist Tomogr 1983;7:937-45.
5. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18] fluoro-2-deoxy-d-glucose and MR imaging correlation. Radiology 1993;186:27-35.
6. 18F]fluorodeoxyglucose method. J Cereb Blood Flow Metab 1982;2:163-71.
7. Suzuki M, Shimamura T. Morphological study of the axial view of the cervical spinal cord by MRI images. J Jpn Orthop Assoc 1994; 68:1-13.
8. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Perfornance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-406.
9. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol 1979;6:371-88.
10. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-82.
11. Okada J, Yoshikawa K, Imazeki K, et al. Change of cerebral glucose metabolism by antineoplastic drug. Am J Physiol Imag 1991; 6:162-6.
12. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988;29:1521-5.
13. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102:281-8.
14. Uematsu H, Sadato N, Yonekura Y, et al. FDG uptake in normal extracranial head and neck structures: three dimensional approach with high resolution PET. J Nucl Med 1996;37:251.
15. Melcher CL, Shweizer JS. A promising new scintillator: cerium-doped lutetium oxyorthosilicate. Nucl Instr Methods 1992;314: 212-4.
16. Hudson H, Larkin R. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imag 1994;13: 601-9.
17. Keyes JW. SUV: standard uptake or silly useless value? J Nucl Med 1995;36:1836-9.